Global Over the Counter (OTC) Drugs & Dietary Supplements Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Over the Counter (OTC) Drugs & Dietary Supplements Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. Dietary supplements are products intended to supplement the diet. They are not drugs and, therefore, are not intended to treat, diagnose, mitigate, prevent, or cure diseases. This report analyzed both OTC drugs and dietary supplements.
Over the Counter (OTC) Drugs & Dietary Supplements report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Over the Counter (OTC) Drugs & Dietary Supplements market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Over the Counter (OTC) Drugs & Dietary Supplements industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Over the Counter (OTC) Drugs & Dietary Supplements key companies include Pfizer Inc., Novartis International AG, Roche Holding AG, Merck & Co., Inc., Sanofi S.A, Johnson & Johnson, Gilead Sciences, GlaxoSmithKline plc. and Bayer Healthcare AG, etc. Pfizer Inc., Novartis International AG, Roche Holding AG are top 3 players and held % share in total in 2022.
Over the Counter (OTC) Drugs & Dietary Supplements can be divided into Analgesic & Pain Relievers, Dermatological Products, Cough, Cold, and Flu Products and Vitamin Supplements, etc. Analgesic & Pain Relievers is the mainstream product in the market, accounting for % share globally in 2022.
Over the Counter (OTC) Drugs & Dietary Supplements is widely used in various fields, such as Hospital Pharmacies, Retail Pharmacies, Online Pharmacy and Others, etc. Hospital Pharmacies provides greatest supports to the Over the Counter (OTC) Drugs & Dietary Supplements industry development. In 2022, global % share of Over the Counter (OTC) Drugs & Dietary Supplements went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Over the Counter (OTC) Drugs & Dietary Supplements market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Pfizer Inc.
Novartis International AG
Roche Holding AG
Merck & Co., Inc.
Sanofi S.A
Johnson & Johnson
Gilead Sciences
GlaxoSmithKline plc.
Bayer Healthcare AG
AstraZeneca plc.
Alacer Corp.
Alcon Inc.
Alfresa Pharma Corporation
Alkalon A/S
Alliance Healthcare
Allergan, Plc.
Reckitt Benckiser Plc.
Bausch & Lomb
AbbVie Inc.
The Colgate-Palmolive Company
Segment by Type
Analgesic & Pain Relievers
Dermatological Products
Cough, Cold, and Flu Products
Vitamin Supplements
Mineral Supplements
Ophthalmic Products
Hospital Pharmacies
Retail Pharmacies
Online Pharmacy
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Over the Counter (OTC) Drugs & Dietary Supplements market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Over the Counter (OTC) Drugs & Dietary Supplements introduction, etc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Over the Counter (OTC) Drugs & Dietary Supplements market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Over the Counter (OTC) Drugs & Dietary Supplements report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Over the Counter (OTC) Drugs & Dietary Supplements market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Over the Counter (OTC) Drugs & Dietary Supplements industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Over the Counter (OTC) Drugs & Dietary Supplements key companies include Pfizer Inc., Novartis International AG, Roche Holding AG, Merck & Co., Inc., Sanofi S.A, Johnson & Johnson, Gilead Sciences, GlaxoSmithKline plc. and Bayer Healthcare AG, etc. Pfizer Inc., Novartis International AG, Roche Holding AG are top 3 players and held % share in total in 2022.
Over the Counter (OTC) Drugs & Dietary Supplements can be divided into Analgesic & Pain Relievers, Dermatological Products, Cough, Cold, and Flu Products and Vitamin Supplements, etc. Analgesic & Pain Relievers is the mainstream product in the market, accounting for % share globally in 2022.
Over the Counter (OTC) Drugs & Dietary Supplements is widely used in various fields, such as Hospital Pharmacies, Retail Pharmacies, Online Pharmacy and Others, etc. Hospital Pharmacies provides greatest supports to the Over the Counter (OTC) Drugs & Dietary Supplements industry development. In 2022, global % share of Over the Counter (OTC) Drugs & Dietary Supplements went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Over the Counter (OTC) Drugs & Dietary Supplements market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Pfizer Inc.
Novartis International AG
Roche Holding AG
Merck & Co., Inc.
Sanofi S.A
Johnson & Johnson
Gilead Sciences
GlaxoSmithKline plc.
Bayer Healthcare AG
AstraZeneca plc.
Alacer Corp.
Alcon Inc.
Alfresa Pharma Corporation
Alkalon A/S
Alliance Healthcare
Allergan, Plc.
Reckitt Benckiser Plc.
Bausch & Lomb
AbbVie Inc.
The Colgate-Palmolive Company
Segment by Type
Analgesic & Pain Relievers
Dermatological Products
Cough, Cold, and Flu Products
Vitamin Supplements
Mineral Supplements
Ophthalmic Products
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacy
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Over the Counter (OTC) Drugs & Dietary Supplements market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Over the Counter (OTC) Drugs & Dietary Supplements introduction, etc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Over the Counter (OTC) Drugs & Dietary Supplements market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices